RT Journal Article SR Electronic T1 Prenatal maternal distress during the COVID-19 pandemic and its effects on the infant brain JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2021.10.04.21264536 DO 10.1101/2021.10.04.21264536 A1 Kathryn Y. Manning A1 Xiangyu Long A1 Dana Watts A1 Lianne Tomfohr-Madsen A1 Gerald F. Giesbrecht A1 Catherine Lebel YR 2021 UL http://medrxiv.org/content/early/2021/10/07/2021.10.04.21264536.abstract AB The COVID-19 pandemic has caused elevated distress in pregnant individuals, which has the potential to impact the developing infant. In this study, we examined anxiety and depression symptoms during the pandemic in a large sample of pregnant individuals (n=8602). For a sub-sample of participants, their infants underwent magnetic resonance imaging (MRI) at 3-months of age to examine whether this prenatal maternal distress was associated with infant brain changes. We found significantly elevated prenatal maternal distress compared to pre-pandemic rates, with 47% and 33% of participants reporting clinically significant symptoms of anxiety and depression, respectively. Importantly, we identified social support as a protective factor for clinically elevated prenatal maternal distress. We found significant relationships between prenatal maternal distress and infant amygdala-prefrontal microstructural and functional connectivity and demonstrate for the first time that social support moderates this relationship. Our findings suggest a potentially long-lasting impact of the COVID-19 pandemic on children and show that social support acts as a protective factor not just for pregnant individuals, but also for their developing infants. These findings provide timely evidence to inform clinical practice and policy surrounding the care of pregnant individuals and highlight the importance of social support.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Alberta Childrens Hospital Research Institute and the Owerko Centre for Neurodevelopment and Mental Health. C.L. receives funding from the Canada Research Chair program. K.Y.M was supported by the T. Chen Fong Postdoctoral Fellowship in Medical Imaging Science.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The University of Calgary Conjoint Health Research Ethics Board (CHREB) approved this study and participants provided written consent.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe COVID-19 PdP Study data, including maternal mental health measures and infant imaging data is available upon request.